Evidence map›Paper›PMID 40073265›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Lipin-1 restrains macrophage lipid synthesis to promote inflammation resolution.

Temitayo T Bamgbose, Robert M Schilke, Oluwakemi O Igiehon, Ebubechukwu H Nkadi, Monika Binwal, David Custis, Sushma Bharrhan, Benjamin Schwarz, Eric Bohrnsen, Catharine M Bosio and 4 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Temitayo T BamgboseDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0002-1628-8868
Robert M SchilkeDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0001-7584-8282
Oluwakemi O IgiehonDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0001-8497-2576
Ebubechukwu H NkadiDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0009-0005-7950-4344
Monika BinwalDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0003-4629-6153
David CustisResearch Core Facility, Louisiana State University Health Sciences Center, Shreveport, LA, United States.
Sushma BharrhanCenter for Applied Immunology and Pathological Processes, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0002-0526-4705
Benjamin SchwarzProteins and Chemistry Section, Research and Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT, United States.ORCID 0000-0002-5894-953X
Eric BohrnsenProteins and Chemistry Section, Research and Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT, United States.
Catharine M BosioImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT, United States.
Rona S ScottDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0003-3840-9189
Arif YurdagulDepartment of Molecular and Cellular Physiology, Louisiana State University Health Shreveport, Shreveport, LA, United States.
Brian N FinckDivision of Nutritional Sciences and Obesity Medicine, Washington University School of Medicine in St. Louis, St Louis, MO, United States.ORCID 0000-0001-5411-3674
Matthew D WoolardDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.ORCID 0000-0002-8497-5838

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Dysregulations in Polyamine Metabolism During AtherosclerosisR01HL167758 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Arif Yurdagul · 2023 to 2026
$2.2M
Lipin-1 transcriptional coregulatory activity promotes macrophage pro-resolving responseR01HL163106 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Matthew Dale Woolard · 2023 to 2026
$2.2M
LIPIN 1 AND CARDIAC METABOLISM IN THE CONTEXT OF LIPID OVERLOADR01HL119225 · NHLBI · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2014 to 2017
$1.5M
Macrophage- associated lipin-1 lipid synthesis regulates foam cell inflammatory responsesR01HL131844 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WOOLARD, MATTHEW DALE · 2017 to 2020
$1.4M
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis RegressionR00HL145131 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI YURDAGUL, ARIF · 2021 to 2023
$747k
National Institute of Allergy and Infectious DiseasesNHLBI NIH HHS R00 HL145131NHLBI NIH HHS R01 HL119225NHLBI NIH HHS R01 HL131844NHLBI NIH HHS R01 HL163106NHLBI NIH HHS R01 HL167758NIDDK NIH HHS P30 DK056341NIGMS NIH HHS P20 GM134974NIH HHSNIH HHS R01HL163106
6 · The paper itself

Abstract

Macrophages are critical to maintaining and restoring tissue homeostasis during inflammation. The lipid metabolic state of macrophages influences their function and polarization, which is crucial to the resolution of inflammation. The contribution of lipid synthesis to proinflammatory macrophage responses is well understood. However, how lipid synthesis regulates proresolving macrophage responses needs to be better understood. Lipin-1 is a phosphatidic acid phosphatase with a transcriptional coregulatory activity that regulates lipid metabolism. We previously demonstrated that lipin-1 supports proresolving macrophage responses, and here, myeloid-associated lipin-1 is required for inflammation resolution, yet how lipin-1-regulated cellular mechanisms promote macrophage proresolution responses is unknown. We demonstrated that the loss of lipin-1 in macrophages led to increased free fatty acid, neutral lipid, and ceramide content and increased phosphorylation of acetyl-CoA carboxylase. The inhibition of the first step of lipid synthesis, the transport of citrate from the mitochondria, reduced lipid content and restored efferocytosis and inflammation resolution in lipin-1mKO mice and macrophages. Our findings suggest macrophage-associated lipin-1 restrains lipid synthesis, promoting proresolving macrophage function in response to proresolving stimuli.

Indexed as

InflammationLipid MetabolismLipidsLipogenesisMacrophagesPhosphatidate PhosphataseAnimalsCeramidesMiceMice, Inbred C57BLMice, KnockoutPhagocytosisCeramidesLipidsLpin1 protein, mousePhosphatidate Phosphatasecitrate carrierefferocytosisfatty acidinflammation resolutionlipin-1

Identifiers

PMID40073265
PMCPMC11844145

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.